SuperiorGroup of Companies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
SuperiorGroup of Companies Inc
SGC · NASDAQ · USD · Market cap $209M · 6,520 employees
Superior Group of Companies, Inc.
Not yet scoredPrice as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price13.31 USD at the 5 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 5 Nov 2026
- Our regime readAccumulation, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.00)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $14.40 to $23.28, base estimate $18.31 (screen dated 2026-11-05).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.00, read 2026-11-05
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
SuperiorGroup of Companies Inc holds its Accumulation at $13.31. The statistical read favours the sellers, held for 42 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 42 days |
| Price at the screen | $13.31 |
| Valuation | 23.85 trailing · 15.50 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.45 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 25.12% | Below 33% | Interest-bearing debt is just 25.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 30.35% | Below 49% | Money owed to the company is 30.3% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
SuperiorGroup of Companies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
SuperiorGroup of Companies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 25%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 23% discount to our $18.31 fair value, none competitive moat, 2.60% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 27.3% discount to the base estimate.
Third-party analyst targets. The average target sits +35% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $18.31, with a range of $14.40 to $23.28, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 3%-growth business trading at just 15.5x forward earnings, with a none competitive moat and minimal debt. That is a 23% discount to our $18.31 fair value: the market is pricing it cautiously while the fundamentals argue otherwise.
| Forward P/E | 15.5xexpensive even after accounting for its growth |
| Trailing P/E | 23.9xa premium valuation |
| EPS, trailing | 0.55 |
| EPS, forward | 0.85 |
| Revenue growth | +2.6%slow but positive growth |
| Profit margin | 1.4%barely profitable |
| Return on equity | 4.3%a modest return on shareholder capital |
| FCF yield | 14.01% |
| Dividend yield | 403.00% |
| Debt to equity | 0.48minimal debt: a conservative balance sheet |
| Current ratio | 2.60comfortably covers its short-term bills |
| Beta | 1.45moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 8.30 - 14.59 |
| Moat | NONE |
| Market cap | $209M |
| Employees | 6,520 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSGC trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $17.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $17.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $17.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $17.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $17.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $17.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $17.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $17.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Superior Group (SGC) Declines More Than Market: Some Information for Investors Yahoo Finance · 28 Sep 2026
- Is It Worth Investing in Superior Group (SGC) Based on Wall Street's Bullish Views? Yahoo Finance · 23 Sep 2026
- Superior Group (SGC) Stock Moves 2.27%: What You Should Know Yahoo Finance · 22 Sep 2026
- lululemon Refreshes Product Strategy: Will New Styles Click? Yahoo Finance · 18 Sep 2026
- ROST Sees Strong Closeout Supply: Is Off-Price Set to Benefit? Yahoo Finance · 18 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $11.23 | +18.9% | $0.14 | $1,202 | +20.2% |
| 2 months | $10.63 | +25.6% | $0.14 | $1,269 | +26.9% |
| 3 months | $10.00 | +33.5% | $0.14 | $1,349 | +34.9% |
| 6 months | $9.94 | +34.3% | $0.28 | $1,371 | +37.1% |
| 1 year | $10.04 | +32.9% | $0.56 | $1,385 | +38.5% |
| 2 years | $19.22 | -30.6% | $1.12 | $753 | -24.7% |
| 3 years | $7.50 | +78.0% | $1.68 | $2,004 | +100.4% |
| 5 years | $20.21 | -33.9% | $2.74 | $796 | -20.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SGC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.